Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

3.

Insulin degrading enzyme induces a conformational change in varicella-zoster virus gE, and enhances virus infectivity and stability.

Li Q, Ali MA, Wang K, Sayre D, Hamel FG, Fischer ER, Bennett RG, Cohen JI.

PLoS One. 2010 Jun 25;5(6):e11327. doi: 10.1371/journal.pone.0011327.

4.
5.

Deletion of the first cysteine-rich region of the varicella-zoster virus glycoprotein E ectodomain abolishes the gE and gI interaction and differentially affects cell-cell spread and viral entry.

Berarducci B, Rajamani J, Reichelt M, Sommer M, Zerboni L, Arvin AM.

J Virol. 2009 Jan;83(1):228-40. doi: 10.1128/JVI.00913-08. Epub 2008 Oct 22.

6.

Varicella-zoster virus glycoprotein E is a critical determinant of virulence in the SCID mouse-human model of neuropathogenesis.

Zerboni L, Berarducci B, Rajamani J, Jones CD, Zehnder JL, Arvin A.

J Virol. 2011 Jan;85(1):98-111. doi: 10.1128/JVI.01902-10. Epub 2010 Oct 20.

7.

Insulin-degrading enzyme binds to the nonglycosylated precursor of varicella-zoster virus gE protein found in the endoplasmic reticulum.

Carpenter JE, Jackson W, de Souza GA, Haarr L, Grose C.

J Virol. 2010 Jan;84(2):847-55. doi: 10.1128/JVI.01801-09. Epub 2009 Oct 28.

8.

Functions of the unique N-terminal region of glycoprotein E in the pathogenesis of varicella-zoster virus infection.

Berarducci B, Rajamani J, Zerboni L, Che X, Sommer M, Arvin AM.

Proc Natl Acad Sci U S A. 2010 Jan 5;107(1):282-7. doi: 10.1073/pnas.0912373107. Epub 2009 Dec 4.

9.
10.
11.

Varicella-zoster virus glycoprotein I is essential for spread in dorsal root ganglia and facilitates axonal localization of structural virion components in neuronal cultures.

Christensen J, Steain M, Slobedman B, Abendroth A.

J Virol. 2013 Dec;87(24):13719-28. doi: 10.1128/JVI.02293-13. Epub 2013 Oct 9.

12.
13.

Stability of a varicella-zoster virus glycoprotein E epitope.

Vafai A, Forghani B, Kilpatrick D, Ling J, Shankar V.

Arch Virol. 2000;145(1):85-97.

PMID:
10664408
14.

Immunogenicity of a recombinant varicella-zoster virus gE-IE63 fusion protein, a putative vaccine candidate against primary infection and zoster reactivation.

Jacquet A, Haumont M, Massaer M, Garcia L, Mazzu P, Daminet V, Grégoire D, Jacobs P, Bollen A.

Vaccine. 2002 Feb 22;20(11-12):1593-602.

PMID:
11858867
16.

Investigation of varicella-zoster virus neurotropism and neurovirulence using SCID mouse-human DRG xenografts.

Zerboni L, Arvin A.

J Neurovirol. 2011 Dec;17(6):570-7. doi: 10.1007/s13365-011-0066-x. Epub 2011 Dec 8. Review.

PMID:
22161683
17.
18.

Varicella-zoster virus glycoprotein gE: endocytosis and trafficking of the Fc receptor.

Olson JK, Santos RA, Grose C.

J Infect Dis. 1998 Nov;178 Suppl 1:S2-6.

PMID:
9852964
19.

Varicella virus-mononuclear cell interaction.

White TM, Gilden DH.

Adv Virus Res. 2003;62:1-17. Review.

PMID:
14719363
20.

[Varicella-zoster virus (VZV)].

Kanai K, Yamada S, Inoue N.

Uirusu. 2010 Dec;60(2):197-207. Review. Japanese.

Supplemental Content

Support Center